Lipidor AB: A Snapshot of the Swedish Healthcare Company

Lipidor AB, a Swedish healthcare company headquartered in Stockholm, has been making strides in the health care sector with its focus on manufacturing and developing lipids and related products. These products are primarily designed for topical administration and cater to the pharmaceutical, wound care, and skin care markets. The company’s operations are exclusive to Sweden, and it is listed on the Swedish Stock Exchange.

As of May 8, 2025, Lipidor AB’s close price stood at 0.25 SEK. The company’s stock has experienced fluctuations over the past year, with a 52-week high of 0.5 SEK recorded on June 9, 2024, and a 52-week low of 0.04 SEK on July 2, 2024. Despite these variations, Lipidor AB maintains a market capitalization of 203,350,928 SEK.

Lipidor AB’s commitment to innovation in the health care sector is evident through its specialized product offerings. By focusing on lipids for topical use, the company addresses a niche yet significant segment of the health care market, providing solutions for pharmaceutical applications, wound care, and skin care needs.

The company’s presence on the Swedish Stock Exchange underscores its role in the Swedish health care industry and its potential for growth and development within the sector. As Lipidor AB continues to expand its product range and market reach, it remains a noteworthy player in the health care landscape in Sweden.